Opus Genetics Inc

IRDNASDAQ · USD
5.22USD0.00 (+0.78%)
1210

Opus Genetics Inc (IRD) Options Open Interest

IRD options open interest is 8,126 contracts. The 2-week average daily volume is 2,276 contracts across the chain.

Read more

Monitoring IRD open interest helps you see where real money is positioned on Opus Genetics Inc's options and which strikes are attracting the most commitment from traders. Opus Genetics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor IRD options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising IRD options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Opus Genetics Inc to settle.

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy.

The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where IRD open interest is concentrated. Our scanner maps Opus Genetics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Opus Genetics Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
5.000.600.800.70108%+0.60932,802
7.500.350.35171%+0.2893361
2.500.604.102.3523%+1.000043
10.002.752.75687%+0.72170
Puts
5.000.550.55117%-0.3899126
2.500.200.20263%-0.084336
7.501.553.102.3381%-0.940136
10.004.107.005.55316%-0.62822

As of September 21, 2026

Follow the money

Track IRD open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial